IDEXX Labs (IDXX) Tops Q2 EPS by 10c, Beats on Revenues; Offers FY17 EPS / Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
IDEXX (IDXX) Oversold, Buy on Weakness - Stifel
August 1, 2017 12:31 PM EDTStifel analyst Jonathan Block sees shares of IDEXX Laboratories (NASDAQ: IDXX) as oversold and reiterated a Buy rating and price target of $185.
Block called the quarter "solid" with a raised outlook but notes shares are under pressure as the magnitude of the beat and... More
CL King Upgrades IDEXX Laboratories (IDXX) to Buy
July 28, 2017 9:26 AM EDTCL King upgraded IDEXX Laboratories (NASDAQ: IDXX) from Neutral to Buy with a price target of $200.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $164.40 yesterday.
... More